COVID-19 Impact on In Vitro Toxicity Market, Global Research Reports 2020-2021
This report covers market size and forecasts of In Vitro Toxicity, including the following market information:
Major competitors identified in this market include Agilent Technologies, Covance, Bio-Rad Laboratories, General Electric, Eurofins Scientific, BioReliance, Charles River Laboratories International, Thermo Fisher Scientific, Catalent, Cyprotex, etc.
Based on the Region:
- Global In Vitro Toxicity Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global In Vitro Toxicity Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global In Vitro Toxicity Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global In Vitro Toxicity Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Agilent Technologies, Covance, Bio-Rad Laboratories, General Electric, Eurofins Scientific, BioReliance, Charles River Laboratories International, Thermo Fisher Scientific, Catalent, Cyprotex, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Dose Response
- Threshold Response
- Distribution
- Excretion
- Metabolism
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on In Vitro Toxicity Industry
1.7 COVID-19 Impact: In Vitro Toxicity Market Trends
2 GLOBAL IN VITRO TOXICITY QUARTERLY MARKET SIZE ANALYSIS
2.1 In Vitro Toxicity Business Impact Assessment - COVID-19
2.1.1 Global In Vitro Toxicity Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global In Vitro Toxicity Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global In Vitro Toxicity Quarterly Market Size, 2019 VS 2020
3.2 By Players, In Vitro Toxicity Headquarters and Area Served
3.3 Date of Key Players Enter into In Vitro Toxicity Market
3.4 Key Players In Vitro Toxicity Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON IN VITRO TOXICITY SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Dose Response
1.4.2 Threshold Response
4.2 By Type, Global In Vitro Toxicity Market Size, 2019-2021
5 IMPACT OF COVID-19 ON IN VITRO TOXICITY SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Distribution
5.5.2 Excretion
5.5.3 Metabolism
5.2 By Application, Global In Vitro Toxicity Market Size, 2019-2021
5.2.1 By Application, Global In Vitro Toxicity Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Agilent Technologies
7.1.1 Agilent Technologies Business Overview
7.1.2 Agilent Technologies In Vitro Toxicity Quarterly Revenue, 2020
7.1.3 Agilent Technologies In Vitro Toxicity Product Introduction
7.1.4 Agilent Technologies Response to COVID-19 and Related Developments
7.2 Covance
7.2.1 Covance Business Overview
7.2.2 Covance In Vitro Toxicity Quarterly Revenue, 2020
7.2.3 Covance In Vitro Toxicity Product Introduction
7.2.4 Covance Response to COVID-19 and Related Developments
7.3 Bio-Rad Laboratories
7.3.1 Bio-Rad Laboratories Business Overview
7.3.2 Bio-Rad Laboratories In Vitro Toxicity Quarterly Revenue, 2020
7.3.3 Bio-Rad Laboratories In Vitro Toxicity Product Introduction
7.3.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments
7.4 General Electric
7.4.1 General Electric Business Overview
7.4.2 General Electric In Vitro Toxicity Quarterly Revenue, 2020
7.4.3 General Electric In Vitro Toxicity Product Introduction
7.4.4 General Electric Response to COVID-19 and Related Developments
7.5 Eurofins Scientific
7.5.1 Eurofins Scientific Business Overview
7.5.2 Eurofins Scientific In Vitro Toxicity Quarterly Revenue, 2020
7.5.3 Eurofins Scientific In Vitro Toxicity Product Introduction
7.5.4 Eurofins Scientific Response to COVID-19 and Related Developments
7.6 BioReliance
7.6.1 BioReliance Business Overview
7.6.2 BioReliance In Vitro Toxicity Quarterly Revenue, 2020
7.6.3 BioReliance In Vitro Toxicity Product Introduction
7.6.4 BioReliance Response to COVID-19 and Related Developments
7.7 Charles River Laboratories International
7.7.1 Charles River Laboratories International Business Overview
7.7.2 Charles River Laboratories International In Vitro Toxicity Quarterly Revenue, 2020
7.7.3 Charles River Laboratories International In Vitro Toxicity Product Introduction
7.7.4 Charles River Laboratories International Response to COVID-19 and Related Developments
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Business Overview
7.8.2 Thermo Fisher Scientific In Vitro Toxicity Quarterly Revenue, 2020
7.8.3 Thermo Fisher Scientific In Vitro Toxicity Product Introduction
7.8.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
7.9 Catalent
7.9.1 Catalent Business Overview
7.9.2 Catalent In Vitro Toxicity Quarterly Revenue, 2020
7.9.3 Catalent In Vitro Toxicity Product Introduction
7.9.4 Catalent Response to COVID-19 and Related Developments
7.10 Cyprotex
7.10.1 Cyprotex Business Overview
7.10.2 Cyprotex In Vitro Toxicity Quarterly Revenue, 2020
7.10.3 Cyprotex In Vitro Toxicity Product Introduction
7.10.4 Cyprotex Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on In Vitro Toxicity Industry
1.7 COVID-19 Impact: In Vitro Toxicity Market Trends
2 GLOBAL IN VITRO TOXICITY QUARTERLY MARKET SIZE ANALYSIS
2.1 In Vitro Toxicity Business Impact Assessment - COVID-19
2.1.1 Global In Vitro Toxicity Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global In Vitro Toxicity Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global In Vitro Toxicity Quarterly Market Size, 2019 VS 2020
3.2 By Players, In Vitro Toxicity Headquarters and Area Served
3.3 Date of Key Players Enter into In Vitro Toxicity Market
3.4 Key Players In Vitro Toxicity Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON IN VITRO TOXICITY SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Dose Response
1.4.2 Threshold Response
4.2 By Type, Global In Vitro Toxicity Market Size, 2019-2021
5 IMPACT OF COVID-19 ON IN VITRO TOXICITY SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Distribution
5.5.2 Excretion
5.5.3 Metabolism
5.2 By Application, Global In Vitro Toxicity Market Size, 2019-2021
5.2.1 By Application, Global In Vitro Toxicity Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Agilent Technologies
7.1.1 Agilent Technologies Business Overview
7.1.2 Agilent Technologies In Vitro Toxicity Quarterly Revenue, 2020
7.1.3 Agilent Technologies In Vitro Toxicity Product Introduction
7.1.4 Agilent Technologies Response to COVID-19 and Related Developments
7.2 Covance
7.2.1 Covance Business Overview
7.2.2 Covance In Vitro Toxicity Quarterly Revenue, 2020
7.2.3 Covance In Vitro Toxicity Product Introduction
7.2.4 Covance Response to COVID-19 and Related Developments
7.3 Bio-Rad Laboratories
7.3.1 Bio-Rad Laboratories Business Overview
7.3.2 Bio-Rad Laboratories In Vitro Toxicity Quarterly Revenue, 2020
7.3.3 Bio-Rad Laboratories In Vitro Toxicity Product Introduction
7.3.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments
7.4 General Electric
7.4.1 General Electric Business Overview
7.4.2 General Electric In Vitro Toxicity Quarterly Revenue, 2020
7.4.3 General Electric In Vitro Toxicity Product Introduction
7.4.4 General Electric Response to COVID-19 and Related Developments
7.5 Eurofins Scientific
7.5.1 Eurofins Scientific Business Overview
7.5.2 Eurofins Scientific In Vitro Toxicity Quarterly Revenue, 2020
7.5.3 Eurofins Scientific In Vitro Toxicity Product Introduction
7.5.4 Eurofins Scientific Response to COVID-19 and Related Developments
7.6 BioReliance
7.6.1 BioReliance Business Overview
7.6.2 BioReliance In Vitro Toxicity Quarterly Revenue, 2020
7.6.3 BioReliance In Vitro Toxicity Product Introduction
7.6.4 BioReliance Response to COVID-19 and Related Developments
7.7 Charles River Laboratories International
7.7.1 Charles River Laboratories International Business Overview
7.7.2 Charles River Laboratories International In Vitro Toxicity Quarterly Revenue, 2020
7.7.3 Charles River Laboratories International In Vitro Toxicity Product Introduction
7.7.4 Charles River Laboratories International Response to COVID-19 and Related Developments
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Business Overview
7.8.2 Thermo Fisher Scientific In Vitro Toxicity Quarterly Revenue, 2020
7.8.3 Thermo Fisher Scientific In Vitro Toxicity Product Introduction
7.8.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
7.9 Catalent
7.9.1 Catalent Business Overview
7.9.2 Catalent In Vitro Toxicity Quarterly Revenue, 2020
7.9.3 Catalent In Vitro Toxicity Product Introduction
7.9.4 Catalent Response to COVID-19 and Related Developments
7.10 Cyprotex
7.10.1 Cyprotex Business Overview
7.10.2 Cyprotex In Vitro Toxicity Quarterly Revenue, 2020
7.10.3 Cyprotex In Vitro Toxicity Product Introduction
7.10.4 Cyprotex Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on In Vitro Toxicity Assessment
Table 9. COVID-19 Impact: In Vitro Toxicity Market Trends
Table 10. COVID-19 Impact Global In Vitro Toxicity Market Size
Table 11. Global In Vitro Toxicity Quarterly Market Size, 2020 (US$ Million)
Table 12. Global In Vitro Toxicity Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global In Vitro Toxicity Market Growth Drivers
Table 14. Global In Vitro Toxicity Market Restraints
Table 15. Global In Vitro Toxicity Market Opportunities
Table 16. Global In Vitro Toxicity Market Challenges
Table 17. By Players, In Vitro Toxicity Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, In Vitro Toxicity Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key In Vitro Toxicity Players Headquarters and Area Served
Table 20. Date of Key Players Enter into In Vitro Toxicity Market
Table 21. Key Players In Vitro Toxicity Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global In Vitro Toxicity Market Size 2019-2021, (US$ Million)
Table 24. Global In Vitro Toxicity Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global In Vitro Toxicity Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 57. Agilent Technologies Business Overview
Table 58. Agilent Technologies In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Agilent Technologies In Vitro Toxicity Product
Table 60. Agilent Technologies Response to COVID-19 and Related Developments
Table 61. Covance Business Overview
Table 62. Covance In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Covance In Vitro Toxicity Product
Table 64. Covance Response to COVID-19 and Related Developments
Table 65. Bio-Rad Laboratories Business Overview
Table 66. Bio-Rad Laboratories In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Bio-Rad Laboratories In Vitro Toxicity Product
Table 68. Bio-Rad Laboratories Response to COVID-19 and Related Developments
Table 69. General Electric Business Overview
Table 70. General Electric In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. General Electric In Vitro Toxicity Product
Table 72. General Electric Response to COVID-19 and Related Developments
Table 73. Eurofins Scientific Business Overview
Table 74. Eurofins Scientific In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Eurofins Scientific In Vitro Toxicity Product
Table 76. Eurofins Scientific Response to COVID-19 and Related Developments
Table 77. BioReliance Business Overview
Table 78. BioReliance In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. BioReliance In Vitro Toxicity Product
Table 80. BioReliance Response to COVID-19 and Related Developments
Table 81. Charles River Laboratories International Business Overview
Table 82. Charles River Laboratories International In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Charles River Laboratories International In Vitro Toxicity Product
Table 84. Charles River Laboratories International Response to COVID-19 and Related Developments
Table 85. Thermo Fisher Scientific Business Overview
Table 86. Thermo Fisher Scientific In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Thermo Fisher Scientific In Vitro Toxicity Product
Table 88. Thermo Fisher Scientific Response to COVID-19 and Related Developments
Table 89. Catalent Business Overview
Table 90. Catalent In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Catalent In Vitro Toxicity Product
Table 92. Catalent Response to COVID-19 and Related Developments
Table 93. Cyprotex Business Overview
Table 94. Cyprotex In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Cyprotex In Vitro Toxicity Product
Table 96. Cyprotex Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on In Vitro Toxicity Assessment
Table 9. COVID-19 Impact: In Vitro Toxicity Market Trends
Table 10. COVID-19 Impact Global In Vitro Toxicity Market Size
Table 11. Global In Vitro Toxicity Quarterly Market Size, 2020 (US$ Million)
Table 12. Global In Vitro Toxicity Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global In Vitro Toxicity Market Growth Drivers
Table 14. Global In Vitro Toxicity Market Restraints
Table 15. Global In Vitro Toxicity Market Opportunities
Table 16. Global In Vitro Toxicity Market Challenges
Table 17. By Players, In Vitro Toxicity Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, In Vitro Toxicity Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key In Vitro Toxicity Players Headquarters and Area Served
Table 20. Date of Key Players Enter into In Vitro Toxicity Market
Table 21. Key Players In Vitro Toxicity Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global In Vitro Toxicity Market Size 2019-2021, (US$ Million)
Table 24. Global In Vitro Toxicity Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global In Vitro Toxicity Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa In Vitro Toxicity Market Size, 2019-2021 (US$ Million)
Table 57. Agilent Technologies Business Overview
Table 58. Agilent Technologies In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Agilent Technologies In Vitro Toxicity Product
Table 60. Agilent Technologies Response to COVID-19 and Related Developments
Table 61. Covance Business Overview
Table 62. Covance In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Covance In Vitro Toxicity Product
Table 64. Covance Response to COVID-19 and Related Developments
Table 65. Bio-Rad Laboratories Business Overview
Table 66. Bio-Rad Laboratories In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Bio-Rad Laboratories In Vitro Toxicity Product
Table 68. Bio-Rad Laboratories Response to COVID-19 and Related Developments
Table 69. General Electric Business Overview
Table 70. General Electric In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. General Electric In Vitro Toxicity Product
Table 72. General Electric Response to COVID-19 and Related Developments
Table 73. Eurofins Scientific Business Overview
Table 74. Eurofins Scientific In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Eurofins Scientific In Vitro Toxicity Product
Table 76. Eurofins Scientific Response to COVID-19 and Related Developments
Table 77. BioReliance Business Overview
Table 78. BioReliance In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. BioReliance In Vitro Toxicity Product
Table 80. BioReliance Response to COVID-19 and Related Developments
Table 81. Charles River Laboratories International Business Overview
Table 82. Charles River Laboratories International In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Charles River Laboratories International In Vitro Toxicity Product
Table 84. Charles River Laboratories International Response to COVID-19 and Related Developments
Table 85. Thermo Fisher Scientific Business Overview
Table 86. Thermo Fisher Scientific In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Thermo Fisher Scientific In Vitro Toxicity Product
Table 88. Thermo Fisher Scientific Response to COVID-19 and Related Developments
Table 89. Catalent Business Overview
Table 90. Catalent In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Catalent In Vitro Toxicity Product
Table 92. Catalent Response to COVID-19 and Related Developments
Table 93. Cyprotex Business Overview
Table 94. Cyprotex In Vitro Toxicity Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Cyprotex In Vitro Toxicity Product
Table 96. Cyprotex Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. In Vitro Toxicity Product Picture
Figure 2. In Vitro Toxicity Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global In Vitro Toxicity Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global In Vitro Toxicity Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global In Vitro Toxicity Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global In Vitro Toxicity Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global In Vitro Toxicity Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global In Vitro Toxicity Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific In Vitro Toxicity Market Size Market Share, 2019-2021
Figure 1. In Vitro Toxicity Product Picture
Figure 2. In Vitro Toxicity Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global In Vitro Toxicity Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global In Vitro Toxicity Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global In Vitro Toxicity Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global In Vitro Toxicity Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global In Vitro Toxicity Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global In Vitro Toxicity Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific In Vitro Toxicity Market Size Market Share, 2019-2021
